Prime Therapeutics (Prime) once again had a robust presence at Academy of Managed Care Pharmacy (AMCP) annual meeting from April 13–16 in Nashville, Tennessee. AMCP is the nation’s leading professional association that aims to help patients get the medications they need at a cost they can afford. This event annually attracts thousands of industry leaders, health care professionals and stakeholders committed to advancing the field.  

---

Stories

Prime Therapeutics to present latest industry-leading research at AMCP 2026
Three studies to be recognized with awards
Read more »

Precision medicine is booming for cancer care. What’s next?
Prime Therapeutics experts shared more about the latest in precision oncology at AMCP 2026, including barriers to treatment and the current regulatory landscape
Read more »

Navigating the complex cell and gene therapy market
Prime Therapeutics experts share insights about the classification, cost and impact of these revolutionary drugs
Read more »

How integrated medical and pharmacy benefits improves specialty drug management
Prime Therapeutics experts shared how rising costs are leading to innovation in benefit management
Read more »

Podcast

AMCP 2026: Clinical, health outcomes research helps guide treatment strategy for health care payers, providers and patients
Prime Therapeutics researchers share some of the key takeaways from their work presented at AMCP 2026
Read more »

 

Research & Publications

AMCP 2026 research posters
Prime Therapeutics (Prime) presents studies on CAR T therapies, medical and pharmacy benefit integration, biologics, mental health parity and more
Read more »
 

In the news

Managed Healthcare Executive: Prime Therapeutics experts spotlight evolving oncology trends and the challenge of balancing innovation with cost and access | AMCP Annual 2026
In this first part of a video interview series, Abby Kim, Pharm.D., of Prime Therapeutics shows how advances such as precision medicine and CAR T therapy are improving outcomes while requiring managed care leaders to rethink value through a long-term lens of cost, toxicity and patient access.
Read more »

Managed Healthcare Executive: Data and workflows have to be aligned for integrated pharmacy benefits | AMCP Annual 2026
Read more »

Managed Healthcare Executive: Integrating pharmacy and medical benefits for specialty drug management | AMCP Annual 2026
Read more »

Managed Healthcare Executive: CAR-T cell therapy moves beyond hospitals, raising new questions for payers | AMCP Annual 2026
As CAR-T therapy expands into earlier stages of treatment and new care settings, payers are weighing access, cost savings and utilization management strategies.
Read more »

Managed Healthcare Executive: Gene therapy brims with promise. The reality has been less rosy for some therapies | AMCP Annual 2026
Pfizer and BioMarin have pulled their hemophilia gene therapies, citing low demand.
Read more »

AJMC: Oncology Innovation Outpaces Managed Care’s Ability to Keep Up
Rapid advances in precision oncology are exposing gaps in testing, treatment access, and care delivery, challenging managed care to keep pace.
Read more »

Managed Healthcare Executive: Gene therapy may be a once-in-lifetime treatment. That gives some patients and providers pause and a willingness to ‘wait it out’ until a better therapy comes along | AMCP Annual 2026
Brian MacDonald, Pharm.D., of Prime Therapeutics discusses the low utilization of the gene therapies for hemophilia. Pfizer and BioMarin have pulled their FDA-approved hemophilia gene therapies from the market, citing low demand.
Read more »

Managed Healthcare Executive: Virtual navigation and clinical pathways help reduce costs and improve patient experience in oncology care
At the AMCP Annual Meeting this week, experts from Prime Therapeutics said virtual navigation and clinical pathways are helping lower acute care use, guide treatment decisions and improve outcomes for patients with cancer.
Read more »

AJMC: Oncology Trends and Testing Gaps Shape Precision Care Delivery: Abby Kim, PharmD
Abby Kim, PharmD, delves into oncology trends, biomarker testing gaps, and evolving clinical pathways shaping precision care and treatment decisions.
Read more »

AJMC: GLP-1 Coverage Gaps and Real-World Evidence Shape Access Trends: Ben Urick, PharmD, PhD
Ben Urick, PharmD, PhD, examines GLP-1 coverage gaps and real-world evidence challenges shaping payer decisions and obesity treatment access.
Read more »

Managed Healthcare Executive: Pharmacogenomic testing becomes standard in oncology care amid new guidelines
Read more »

AJMC: Drug-Adjacent Advancements Directing Future Oncology Care: Abby Kim, PharmD
Experts from AMCP emphasize the importance of drug-adjacent early detection tests and screening ability to improve patient outcomes.
Read more »

AJMC: AMCP 2026 Highlights: Managed Care Trends in Oncology, Policy, and Innovation
AMCP 2026 spotlighted oncology innovation, AI, and payer strategies, with KOL insights on cost, access, and evolving managed care trends.
Read more »

Managed Healthcare Executive: Facing the practical problems of gene therapy | AMCP Annual 2026
Read more »

AJMC: Drug-Adjacent Advancements Directing Future Oncology Care: Abby Kim, PharmD
Experts from AMCP emphasize the importance of drug-adjacent early detection tests and screening ability to improve patient outcomes.
Read more »

AJMC: GLP-1 Usage Driving Health Care Spending, Real-World Implications: Ben Urick, PharmD, PhD
Experts from AMCP discuss the real-world evidence on GLP-1 usage and health care spending.
Read more »